Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.494, 2006-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Access to resources
Recommend
Epoetin alfa: improved QOL for patients with anaemia and RA
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :
Epoetin alfa: improved QOL for patients with anaemia and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. :
Infliximab improves QOL in active and fistulising Crohn's disease
Inpharma, Vol. 1, Iss. 1346, 2002-01 ,pp. :
Infliximab's QOL effect clinically meaningful in rheumatic disorders
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :